American Diabetes Association 82nd Scientific Sessions (ADA 2022)

A doctor checks blood sugar levels with a glucometer for type 2 diabetes (T2DM) diagnosis, treatment

Youth-onset T2D patients at high risk of CVD, ESKD

Stephen Padilla, 20220609120000

The risks of cardiovascular disease (CVD) and end-stage kidney disease (ESKD) are elevated twofold in individuals with youth-onset type 2 diabetes (T2D), which is partly caused by the greater burden of obesity and other metabolic risk factors in this population, relative to those with type 1 diabetes (T1D), according to a Hong Kong study.

Novel genetic element ties valine metabolism to heart failure in T2D

Tristan Manalac, 20220609090000

A new study presented at the recent 2022 Scientific Sessions of the American Diabetes Association (ADA 2022) has identified a novel genetic locus associated with heart failure (HF) risk among patients with type 2 diabetes (T2D). This locus appears to play a role in the metabolism of valine, a branched chain amino acid.

SPLENDID unmasks benefits of bariatric surgery in cancer

Elvira Manzano, 20220607000000

New evidence from the SPLENDID study unmasks the benefits of weight loss achieved with bariatric surgery in protecting against cancer.